Our data highlight the significance of the RIT1/PDS5/SMC3 axis in promoting HCC progression and suggest that RIT1 may serve as a biomarker and potential target for HCC diagnosis and therapy (Fig. 8E). This evidence concerns the gene PDS5A and hepatocellular carcinoma.